| | 2009 |
| Company Update
22 December 2009 |
| | SPP Offer of new shares - terms and sample application form
15 December 2009 |
| | 21.8 million new shares placed
11 December 2009 |
| | Becoming a substantial holder
10 December 2009 |
| | A$ 12 Million underwritten placement completed
8 December 2009 |
| | Investor Presentation Share Placement
7 December 2009 |
| | $12million underwritten placement plus share purchase plan
7 December 2009 |
| | Options exercised, shares issued
3 December 2009 |
| | Results of 2009 AGM
5 November 2009 |
| | 2009 AGM presentation
4 November 2009 |
| | Business Update and Appendix 4C Cash Flow statement
30 October 2009 |
| | Directors call options exercised as per details in App3Y
28 October 2009 |
| | Investor Presentation to Wilson HTM
13 October 2009 |
| | Notice of Annual General Meeting
30 September 2009 |
| | Response to price query
22 September 2009 |
| | Options exercised - Shares issued
11 September 2009 |
| | Investor Presentation
24 August 2009 |
| | 2009 Results and 4E Statement
21 August 2009 |
| | Change in Director's interest - exercise of Founder Options
3 August 2009 |
| | 4C Statement for the quarter and year ended 30 June 2009
31 June 2009 |
| | FDA and Regulatory update
10 July 2009 |
| | New Securities issued, Options granted
30 June 2009 |
| | Change of Interests of Substantial Holder
19 June 2009 |
| | Options exercised, New Securities issued, Options lapsed
3 June 2009 |
| | European Launch of Trophon EPR
3 June 2009 |
| | Securities released from escrow, New securities issued
19 May 2009 |
| | Investor Presentation May 2009
13 May 2009 |
| | Nanosonics instructs agent to submit 510(k) application to the US FDA Trophon tender successes
13 May 2009 |
| | New Securities issued, Options exercised, Options lapsed
30 April 2009 |
| | Appendix 4C Consolidated Statement of Cash Flows
30 April 2009 |
| | Securities due for Release from Escrow
28 April 2009 |
| | First Sales of Trophon EPR
30 March 2009 |
| | New Securities issued, Options exercised
23 March 2009 |
| | Change in Director's Interest
23 March 2009 |
| | Change in Director's Interest
25 February 2009 |
| | Nanosonics Interim Report December 2008
16 February 2009 |
| | Appendix 4D Interim Report
16 February 2009 |
| | Changes in Directors
6 February 2009-02-06 |
| | TGA Approves Trophon™ EPR for Commercial Launch in Australia & Overseas
3 February 2009 |
| | 4C Statement of Cash Flows
30 January 2009 |
| |
2008 |
| | Key Commercial Milestones Achieved
12 December 2008 |
| | Change in Director's Interest
19 November 2008 |
| | Results of 2008 AGM
19 November 2008 |
| | Chairman's and CEO's presentations to 2008 AGM
18 November 2008 |
| | Notice of Annual General Meeting
17 October 2008 |
| | CEO Presentation to Wilsons HTM Conference
16 October 2008 |
| | Appointment of Distributor Partners and Consolidated Statement of Cash Flows
16 October 2008 |
| | Health Canada – Approval to Market
9 September 2008 |
| | Confirmation of Expiry Date of Options
22 August 2008 |
| | 2008 Annual Report and 4E Statement
20 August 2008 |
| | Change in Director's Interest
18 August 2008 |
| | Quarterly Update and Consolidated Statement of Cash Flows
30 July 2008 |
| | Appointment of Dr Ron Weinberger as a Director
4 July 2008 |
| | Australian TGA Lodgement
25 June 2008 |
| | Appointment of CEO
4 June 2008 |
| | CE Mark approval awarded for Nanosonics Ultrasound Disinfector
29 April 2008 |
| | Consolidated Statement of Cash Flows (Appendix 4C) for the quarter ended March 2008
24 April 2008 |
| | Half-Yearly Report and Appendix 4D
28 February 2008
|
| | Company update and consolidated statement of cash flows
31 January 2008 |
| | Release of Securities from Escrow and Application for Quotation of Securities
25 January 2008 |
| |
2007 |
| | Director's Final Interest Notice, Options issued, Options lapsed
20 December 2007 |
| | Management Changes
14 December 2007 |
| | AGM Presentation
26 November 2007 |
| | Results of AGM
26 November 2007 |
| | Investor Presentation – Achieving Milestones
7 November 2007 |
| | European CE Mark Technical File Submission
13 November 2007 |
| | Options Exercised, Change in Director’s Interest
8 October 2007 |
| | Company Update and Statement of Cash Flows
30 October 2007 |
| | Combined Letter and Notice of AGM
26 October 2007 |
| | Tapping into International Markets – Presentation prepared for Wilsons Life Sciences Conference
17 October 2007 |
| | Nanosonics receives additional AusIndustry Grant funding for its Ultrasound Probe Disinfector
19 September 2007 |
| | 2007 Annual Report
22 August 2007 |
| | Final Report 4E Statement
22 August 2007 |
| | Operations in Europe and Other Announcements 13 August 2007 |
| | Quarterly Report – Consolidated Statement of Cash Flows
30 July 2007 |
| | Issue of Shares Under 3M Agreement
17 May 2007 |
| | Nanosonics Offer Closes Oversubscribed and Lists on ASX
17 May 2007 |
| | Supplementary Prospectus
27 April 2007 |
| | Nanosonics Prospectus
2 April 2007 |
